Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Wason

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 4, 2019
Overestimated treatment effects in randomised phase II trials: What's up doctor?Stefan Michiels, James Wason
Annals of Neurology|May 19, 2012
Risk in complex genetics: "all models are wrong but some are useful"Stephen Sawcer, James Wason
Statistics in Medicine|July 13, 2012
Identifying combined design and analysis procedures in two-stage trials with a binary end pointJack Bowden, James Wason
Journal of Statistical Planning and Inference|April 23, 2019
Design of experiments for a confirmatory trial of precision medicineKim May Lee, James Wason
BMC Medical Research Methodology|June 26, 2020
Including non-concurrent control patients in the analysis of platform trials: is it worth it?Kim May Lee, James Wason
Trials|May 27, 2020
Analysis of responder-based endpoints: improving power through utilising continuous componentsJames Wason, Martina McMenamin, Susanna Dodd
Annals of Clinical and Translational Neurology|October 31, 2014
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustmentsBarnaby Fiddes, James Wason, Stephen Sawcer
Journal of Clinical Epidemiology|November 11, 2021
Sequential multiple assignment randomized trial studies should report all key components: a systematic reviewTheophile Bigirumurame, Germaine Uwimpuhwe, James Wason
Journal of Neurology|January 14, 2014
Confounding in association studies: month of birth and multiple sclerosisBarnaby Fiddes, James Wason, Stephen Sawcer
Statistics in Medicine|May 23, 2019
To add or not to add a new treatment arm to a multiarm study: A decision-theoretic frameworkKim May Lee, James Wason, Nigel Stallard
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|November 4, 2019
Overestimated treatment effects in randomised phase II trials: What's up doctor?Stefan Michiels, James Wason
Annals of Neurology|May 19, 2012
Risk in complex genetics: "all models are wrong but some are useful"Stephen Sawcer, James Wason
Statistics in Medicine|July 13, 2012
Identifying combined design and analysis procedures in two-stage trials with a binary end pointJack Bowden, James Wason
Journal of Statistical Planning and Inference|April 23, 2019
Design of experiments for a confirmatory trial of precision medicineKim May Lee, James Wason
BMC Medical Research Methodology|June 26, 2020
Including non-concurrent control patients in the analysis of platform trials: is it worth it?Kim May Lee, James Wason
Trials|May 27, 2020
Analysis of responder-based endpoints: improving power through utilising continuous componentsJames Wason, Martina McMenamin, Susanna Dodd
Annals of Clinical and Translational Neurology|October 31, 2014
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustmentsBarnaby Fiddes, James Wason, Stephen Sawcer
Journal of Clinical Epidemiology|November 11, 2021
Sequential multiple assignment randomized trial studies should report all key components: a systematic reviewTheophile Bigirumurame, Germaine Uwimpuhwe, James Wason
Journal of Neurology|January 14, 2014
Confounding in association studies: month of birth and multiple sclerosisBarnaby Fiddes, James Wason, Stephen Sawcer
Statistics in Medicine|May 23, 2019
To add or not to add a new treatment arm to a multiarm study: A decision-theoretic frameworkKim May Lee, James Wason, Nigel Stallard
Pageof 10